Today: 26 April 2026
Browse Category

Stock Market 16 December 2025

Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast shares jumped 4.3% to $29.43 on December 16, 2025, amid heavy trading and speculation about activist investor involvement. The move coincided with the record date for Comcast’s Versant Media Group spin-off, which will distribute Versant shares to eligible holders in early January. No activist investor has been publicly identified.
Warner Bros. Discovery Series A Stock (NASDAQ: WBD) on Dec. 16, 2025: Takeover Battle, Latest News, Analyst Forecasts, and What Comes Next

Warner Bros. Discovery Series A Stock (NASDAQ: WBD) on Dec. 16, 2025: Takeover Battle, Latest News, Analyst Forecasts, and What Comes Next

Warner Bros. Discovery shares traded around $29.25 Tuesday, below Paramount Skydance’s $30-per-share cash offer and above Netflix’s $27.75 implied value. The price reflects investor uncertainty over which deal will close and on what terms. Wall Street banks are competing for advisory roles as the bidding process nears a decision. Comcast’s Versant spinoff is influencing how investors value WBD’s legacy cable networks.
Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)

Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)

Goldman Sachs cut Texas Instruments to Sell from Buy and slashed its price target to $156, citing margin and inventory concerns tied to aggressive capacity expansion. Shares traded around $177.73 midday, down slightly despite the rare double downgrade. Investors weighed the downgrade against a major Sherman, Texas production milestone expected this week.
16 December 2025
Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope shares rose about 7% to $20 by late morning Dec. 16, rebounding after an 8% drop following its first earnings report as a public company. The firm posted $754 million in annual recurring revenue, up 34% year-over-year, and revenue of $184.2 million. Remaining performance obligations topped $1 billion. IPO-related costs drove a headline GAAP operating loss.
Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs Stock (NYSE: CLF) on Dec. 16, 2025: Credit Downgrade, Steel Market Shifts, and the 2026 Profitability Debate

Cleveland-Cliffs shares traded near $12.85 Tuesday after S&P Global Ratings downgraded the company’s credit to ‘B+’ on elevated leverage. The company reported a Q3 net loss of $234 million and revenue of $4.7 billion, while cutting 2025 capex and SG&A forecasts. Investors are watching a major contract change and steel trade policy signals from China.
16 December 2025
Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical Stock (ISRG) News Today: Price Action, Analyst Forecasts, and What to Watch on December 16, 2025

Intuitive Surgical shares fell about 2% to $548–$549 in late morning trading Tuesday, following a 3.17% rebound Monday that ended a five-day losing streak. The company’s market cap stood near $194 billion. Technical analysts noted the stock’s Relative Strength Rating rose to 81. Recent SEC filings showed mixed institutional activity, with Orion Portfolio Solutions increasing its stake and Nilsine Partners reducing holdings.
16 December 2025
Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials (AMAT) Stock News Today (Dec. 16, 2025): Analyst Price Targets Jump as SEMI Forecasts a Record $156B Equipment Market by 2027

Applied Materials shares traded around $257 on Dec. 16, down 1.6%, after recent analyst price-target hikes and bullish industry forecasts tied to AI-driven demand. SEMI projects semiconductor equipment sales will hit $133 billion in 2025, rising to a record $156 billion by 2027, with strong growth in wafer fab and memory equipment.
16 December 2025
Southwest Airlines Stock (NYSE: LUV) Surges on Barclays Upgrade: Today’s News, Analyst Forecasts, and Key Risks (Dec. 16, 2025)

Southwest Airlines Stock (NYSE: LUV) Surges on Barclays Upgrade: Today’s News, Analyst Forecasts, and Key Risks (Dec. 16, 2025)

Southwest Airlines shares rose 2%–3% to around $42–$43 Tuesday after Barclays upgraded the stock to Overweight and raised its price target to $56. The move extended a rally that began in early December. Barclays cited Southwest’s shift toward more segmented pricing and projected earnings above consensus for 2026 and 2027. Broader analyst consensus remains cautious despite the upgrade.
16 December 2025
Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs (GS) Stock News Today: Fed Ends 1MDB-Linked Order as Goldman Targets AI Deals and the 24/7 Trading Era

Goldman Sachs shares traded at $881.68, down 0.9% on Dec. 16, 2025, after the Federal Reserve ended a 2020 enforcement action tied to 1MDB bond deals. The stock remains near its 52-week high of $919.10 set Dec. 11. Investors are weighing the regulatory development, Goldman’s AI- and infrastructure-focused strategy, and industry moves toward near-24-hour U.S. trading.
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson shares fell about 1% to $211–$212 late Tuesday morning after hitting recent highs, following news that the FDA granted a National Priority Voucher for its Tecvayli and Darzalex combination therapy for multiple myeloma. The FDA highlighted strong Phase 3 results and rapid review plans. Investors await the company’s upcoming earnings update for further guidance.
S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

Canada’s S&P/TSX Composite index fell about 0.5% to 31,324 in late-morning trading Tuesday, led by a 3% drop in energy stocks as oil prices slid below $60 on Russia–Ukraine peace hopes. Weak Chinese economic data and oversupply concerns added pressure. Cannabis stocks rose after U.S. President Trump floated marijuana reclassification. Organigram reported record results, boosting sector sentiment.
VIX Today After the Bell: “Fear Gauge” Holds Near 17 as Jobs Data, Yields and Skew Keep Volatility Bid (Dec. 16, 2025)

VIX Today After the Bell: “Fear Gauge” Holds Near 17 as Jobs Data, Yields and Skew Keep Volatility Bid (Dec. 16, 2025)

The Cboe Volatility Index climbed to around 17 by late morning Tuesday, up from Monday’s close, as investors reacted to delayed U.S. macro data and ongoing tech sector volatility. The VIX’s move followed a brief spike in rate-cut expectations after new labor-market figures showed higher unemployment and mixed payrolls. Options markets continued to price in elevated downside protection.
16 December 2025
Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America shares traded at $54.99 as of 16:10 UTC Tuesday, holding near their highest level since 2006. Investors weighed new U.S. jobs data showing nonfarm payrolls up 64,000 in November and a rise in the unemployment rate to 4.6%, which briefly raised odds of a January Fed rate cut. Bank of America’s overdraft and bounced-check fee income rose 2% in the first nine months of 2025.
Rocket Lab Stock (RKLB) News Today: JAXA Mission Win, Launch Abort, Insider Sale Filing, and 2026 Forecasts (Dec. 16, 2025)

Rocket Lab Stock (RKLB) News Today: JAXA Mission Win, Launch Abort, Insider Sale Filing, and 2026 Forecasts (Dec. 16, 2025)

Rocket Lab shares traded at $54.58, down 1.51% midday Tuesday after dropping nearly 10% Monday, despite a successful first dedicated launch for Japan’s space agency last week. The Electron rocket lifted off from New Zealand on December 14, deploying JAXA’s RAISE-4 satellite. The company plans a second JAXA mission in early 2026 and a European Space Agency launch in the new year.
Exxon Mobil (XOM) Stock Slides as Oil Drops Below $60: Today’s News, Analyst Forecasts, and What Investors Are Watching

Exxon Mobil (XOM) Stock Slides as Oil Drops Below $60: Today’s News, Analyst Forecasts, and What Investors Are Watching

Exxon Mobil shares fell about 2% to $115 on Tuesday as oil prices slid, with Brent near $60 and WTI around $56 a barrel. Reuters reported Exxon is among potential bidders for Lukoil’s $22 billion overseas assets, as Lukoil seeks buyers following U.S. sanctions. The deadline for bids was extended to Jan. 17, 2026. Weak Chinese economic data and Russia-Ukraine peace talk optimism also weighed on crude.
BitMine Immersion Technologies (BMNR) Stock News Today (Dec. 16, 2025): ARK Invest Buys the Dip as Ethereum Treasury Nears 4M ETH, Analysts See $47–$60 Targets

BitMine Immersion Technologies (BMNR) Stock News Today (Dec. 16, 2025): ARK Invest Buys the Dip as Ethereum Treasury Nears 4M ETH, Analysts See $47–$60 Targets

BitMine Immersion Technologies (BMNR) traded around $31.14 Tuesday on heavy volume after disclosing it holds nearly 4 million ETH and $1 billion in cash. ARK Invest bought shares following an 11% drop Monday. The company reported adding over 100,000 ETH in a week, aiming for 5% of ETH supply. A new shareholder investigation press release added legal pressure to the volatile stock.

Stock Market Today

  • RE/MAX Holdings (RMAX) Shows Steady Earnings Growth Amid Revenue Decline
    April 26, 2026, 9:33 AM EDT. RE/MAX Holdings (NYSE:RMAX) posts a 7.4% annual growth in earnings per share (EPS) over three years, signaling steady profitability despite a revenue decline. EBIT margins remain flat, raising short-term growth concerns. Significant insider ownership at 5.1% (around $13 million) reflects confidence in the company's strategy. Investors seeking a balance of growth and proven profits might find RMAX worth monitoring, though recent revenue trends warrant caution. RE/MAX illustrates a traditional, profit-focused investment approach amidst a market often favoring high-risk, loss-making tech stocks.

Latest article

PayPal Stock Gets a Fresh Wall Street Lift — But the Sell Rating Says the Hard Part Isn’t Over

PayPal Stock Gets a Fresh Wall Street Lift — But the Sell Rating Says the Hard Part Isn’t Over

26 April 2026
PayPal shares rose 1.5% Friday after Truist Financial raised its price target to $45, though the stock traded at $50.48. The move comes as PayPal faces pressure from missed earnings, a new CEO, and increased competition from Apple Pay and Stripe. PayPal recently launched Curated Ads for connected TV and signed an NFL partnership for peer-to-peer payments. Fourth-quarter revenue rose 4% to $8.68 billion.
Cameco Corporation Stock Slips Before Q1 Results — Why Uranium Investors Are Watching May 5

Cameco Corporation Stock Slips Before Q1 Results — Why Uranium Investors Are Watching May 5

26 April 2026
Cameco’s U.S.-listed shares closed Friday at $122.15, down 1.4% ahead of its first-quarter results due May 5. Uranium prices held at $86.80 a pound, up 30% from a year earlier. Analysts maintain a “Moderate Buy” on the stock, with a C$174.85 target for Toronto-listed shares. Cameco delivered 33 million pounds of uranium in 2025 and holds long-term contracts for about 230 million pounds.
Lockheed Martin Gets Golden Dome Shot as $3.2 Billion Space Shield Race Opens

Lockheed Martin Gets Golden Dome Shot as $3.2 Billion Space Shield Race Opens

26 April 2026
Lockheed Martin was selected for U.S. Space Force prototype work on the $185 billion Golden Dome missile-defense program, joining SpaceX, Northrop Grumman, and Anduril in a crowded field. The awards follow a weak quarter for Lockheed, with profit and cash flow down due to production delays and contract costs. Space Systems Command awarded 20 agreements to 12 companies. Lockheed shares closed at $513.45 on Friday, down 3.08%.
Go toTop